BTIG Remains Positive on NeoGenomics (NEO) Following Q4 Results, Guidance; Affirms at 'Buy'

Go back to BTIG Remains Positive on NeoGenomics (NEO) Following Q4 Results, Guidance; Affirms at 'Buy'
NEOGENOMICS (NASDAQ: NEO) Delayed: 11.47 +0.27 (2.41%)
Previous Close $11.20    52 Week High $9.54 
Open $11.14    52 Week Low $5.49 
Day High $11.68    P/E 286.75 
Day Low $11.13    EPS $0.04 
Volume 3,521,948